Cell Viability Assays Market Report 2024 – Cell Viability Assays Market Trends And Opportunities

The cell viability assays global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Cell Viability Assays Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size –
The cell viability assays market size has grown rapidly in recent years. It will grow from $1.41 billion in 2023 to $1.56 billion in 2024 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to increased investment in cancer research, growth in pharmaceutical R&D expenditure, growth in the biotechnology sector, increased advancements in cell culture techniques, rise in demand for stem cell research, rise in the need for toxicity testing, rise in the utilization of real time cell analysis systems, rise in the number of CROs (contract research organizations).

The cell viability assays market size is expected to see rapid growth in the next few years. It will grow to $2.34 billion in 2028 at a compound annual growth rate (CAGR) of 10.6%.The growth in the forecast period can be attributed to increasing demand for personalized medicine, rise in government funding for cell based research, increasing focus on precision medicine, growth in stem cell research and applications, increasing availability of automated cell viability analyzers, rise in the incidence of infectious diseases, increasing focus on improving assay accuracy and sensitivity, increasing awareness about the benefits of cell viability assays, rise in the development of organ on a chip technologies, increasing demand for regenerative medicine. Major trends in the forecast period include advancement in high throughput screening methods, implementation of AI and machine learning algorithms, development of real time monitoring systems, adoption of automated liquid handling systems, development of multiplex assays to simultaneously measure cell viability, adoption of more sustainable and eco friendly reagents, development of user friendly assay kits, advancement in electrochemical assays, implementation of scalable cell viability assays, development of assays compatible with primary cells and stem cells.

Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/cell-viability-assays-global-market-report

Scope Of Cell Viability Assays Market
The Business Research Company’s reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Cell Viability Assays Market Overview

Market Drivers –
The increasing cell-based therapeutics is expected to propel the growth of the cell viability assay market going forward. Cell-based therapeutics refer to treatments that use living cells to repair or replace damaged tissue, treat diseases, or restore normal function. Cell-based therapeutics are fueled by advances in biotechnology, increasing investment in regenerative medicine, growing acceptance and adoption of cell therapies, and improvements in cell engineering and manufacturing technologies. Cell viability assays support cell-based therapeutics by ensuring the health, functionality, and safety of therapeutic cells, thereby optimizing treatment efficacy and quality control. For instance, according to the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, 38 trials were initiated for non-genetically modified cell therapies in Q1 2023, 7 more than the previous quarter, Q4 2022. Therefore, increasing cell-based therapeutics is driving the growth of the cell viability assay market.

Market Trends –
Major companies operating in the cell viability assays market are developing innovative cell screening technologies to improve accuracy and speed up drug discovery. Cell screening technologies enhance cell viability assays by enabling high-throughput, precise, and rapid analysis of cell health and responses, thus optimizing experimental conditions and improving the development of therapeutic strategies. For instance, in May 2024, Arralyze, a Germany-based technology company, introduced CellShepherd, a cutting-edge platform for single-cell analysis. It utilizes proprietary nanowell glass arrays to miniaturize cell-based assays for real-time monitoring. The autonomous system offers precise cell dispensing, co-culturing in sterile conditions, and imaging with brightfield and fluorescent channels. The AI-driven analysis guarantees accurate cell counting and tracking. This user-friendly platform addresses the increasing need for precise single-cell research in biomedical and life science applications.

The cell viability assays market covered in this report is segmented –

1) By Product: Consumables, Instruments
2) By Application: Basic Research, Stem Cell Research, Drug Discovery And Development, Clinical And Diagnostic Applications, Other Applications
3) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospital And Diagnostic Laboratories, Other End-Users

Get an inside scoop of the cell viability assays market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=16014&type=smp

Regional Insights –
North America was the largest region in the cell viability assays market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell viability assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Key Companies –
Major companies operating in the cell viability assays market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson, and Company, Agilent Technologies Inc., Lonza Group Ltd., PerkinElmer Inc., Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Beckman Coulter Inc., Promega Corporation, Abcam Limited, MP Biomedicals, Cayman Chemical Company, Cell Signaling Technology Inc. , Enzo Biochem Inc., Creative Bioarray, Abnova Corporation, Biotium, Canvax, Nexcelom Bioscience LLC, G-Biosciences, AAT Bioquest Inc.

Table of Contents
1. Executive Summary
2. Cell Viability Assays Market Report Structure
3. Cell Viability Assays Market Trends And Strategies
4. Cell Viability Assays Market – Macro Economic Scenario
5. Cell Viability Assays Market Size And Growth
…..
27. Cell Viability Assays Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model